Accelerate Diagnostics, Inc. (AXDX): Price and Financial Metrics
AXDX Price/Volume Stats
Current price | $5.69 | 52-week high | $17.80 |
Prev. close | $5.75 | 52-week low | $4.50 |
Day low | $5.50 | Volume | 6,889 |
Day high | $5.75 | Avg. volume | 25,937 |
50-day MA | $6.53 | Dividend yield | N/A |
200-day MA | $6.71 | Market Cap | 81.75M |
AXDX Stock Price Chart Interactive Chart >
AXDX POWR Grades
- Growth is the dimension where AXDX ranks best; there it ranks ahead of 78.58% of US stocks.
- The strongest trend for AXDX is in Stability, which has been heading up over the past 177 days.
- AXDX ranks lowest in Momentum; there it ranks in the 5th percentile.
AXDX Stock Summary
- AXDX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 4.74% of US stocks.
- With a year-over-year growth in debt of -67.05%, ACCELERATE DIAGNOSTICS INC's debt growth rate surpasses just 3.25% of about US stocks.
- In terms of volatility of its share price, AXDX is more volatile than 98.8% of stocks we're observing.
- Stocks that are quantitatively similar to AXDX, based on their financial statements, market capitalization, and price volatility, are TTOO, SCKT, XCUR, INSG, and FKWL.
- Visit AXDX's SEC page to see the company's official filings. To visit the company's web site, go to acceleratediagnostics.com.
AXDX Valuation Summary
- In comparison to the median Healthcare stock, AXDX's price/sales ratio is 72.5% higher, now standing at 6.9.
- Over the past 243 months, AXDX's EV/EBIT ratio has gone up 27.7.
Below are key valuation metrics over time for AXDX.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
AXDX | 2023-09-22 | 6.9 | -2.1 | -1.0 | -1.2 |
AXDX | 2023-09-21 | 6.5 | -2.0 | -0.9 | -1.1 |
AXDX | 2023-09-20 | 6.7 | -2.0 | -1.0 | -1.2 |
AXDX | 2023-09-19 | 7.5 | -2.3 | -1.1 | -1.3 |
AXDX | 2023-09-18 | 7.5 | -2.3 | -1.1 | -1.3 |
AXDX | 2023-09-15 | 7.6 | -2.3 | -1.1 | -1.3 |
AXDX Growth Metrics
- The 4 year revenue growth rate now stands at 1513.21%.
- Its year over year revenue growth rate is now at 7.77%.
- Its 4 year cash and equivalents growth rate is now at 298.17%.

The table below shows AXDX's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 13.122 | -51.125 | -70.496 |
2022-06-30 | 13.284 | -50 | -63.777 |
2022-03-31 | 12.221 | -46.554 | -67.648 |
2021-12-31 | 11.782 | -47.323 | -77.702 |
2021-09-30 | 11.547 | -45.719 | -73.811 |
2021-06-30 | 12.013 | -45.927 | -83.582 |
AXDX's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- AXDX has a Quality Grade of D, ranking ahead of 23.75% of graded US stocks.
- AXDX's asset turnover comes in at 0.125 -- ranking 68th of 75 Measuring and Control Equipment stocks.
- AATC, TMO, and BMI are the stocks whose asset turnover ratios are most correlated with AXDX.
The table below shows AXDX's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.125 | 0.366 | -0.333 |
2021-03-31 | 0.112 | 0.379 | -0.320 |
2020-12-31 | 0.103 | 0.399 | -0.302 |
2020-09-30 | 0.097 | 0.418 | -0.316 |
2020-06-30 | 0.079 | 0.458 | -0.343 |
2020-03-31 | 0.071 | 0.467 | -0.358 |
AXDX Price Target
For more insight on analysts targets of AXDX, see our AXDX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $13.00 | Average Broker Recommendation | 1.7 (Moderate Buy) |
Accelerate Diagnostics, Inc. (AXDX) Company Bio
Accelerate Diagnostics is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company was founded in 1982 and is based in Tucson, Arizona.
Latest AXDX News From Around the Web
Below are the latest news stories about ACCELERATE DIAGNOSTICS INC that investors may wish to consider to help them evaluate AXDX as an investment opportunity.
Q2 2023 Accelerate Diagnostics Inc Earnings CallQ2 2023 Accelerate Diagnostics Inc Earnings Call |
Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue EstimatesAccelerate Diagnostics (AXDX) delivered earnings and revenue surprises of -57.33% and 26.98%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? |
Accelerate Diagnostics Reports Second Quarter 2023 Financial ResultsAccelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter for the period ended June 30, 2023. |
Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter ResultsAccelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, August 10, 2023, at 4:30 p.m. Eastern Time to review 2023 second quarter results. |
Accelerate Diagnostics Announces 1-for-10 Reverse Stock SplitAccelerate Diagnostics, Inc., (NASDAQ: AXDX) (the "Company") a leading provider of innovative rapid diagnostic solutions, announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10. The reverse stock split will become effective at 5:00 p.m. Eastern Time, on July 11, 2023. The Company's common stock will begin trading on a post-split basis at the market open on July 12, 2023, under the Company's existing trading symbol "AXDX". The reverse |
AXDX Price Returns
1-mo | -19.29% |
3-mo | N/A |
6-mo | -11.00% |
1-year | -62.57% |
3-year | -94.67% |
5-year | -97.15% |
YTD | -19.41% |
2022 | -86.48% |
2021 | -31.13% |
2020 | -55.15% |
2019 | 46.96% |
2018 | -56.11% |
Continue Researching AXDX
Want to see what other sources are saying about Accelerate Diagnostics Inc's financials and stock price? Try the links below:Accelerate Diagnostics Inc (AXDX) Stock Price | Nasdaq
Accelerate Diagnostics Inc (AXDX) Stock Quote, History and News - Yahoo Finance
Accelerate Diagnostics Inc (AXDX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...